IPsoft develops a free AI-powered Digital Employee to help assess risk for Coronavirus (COVID-19)

• Amelia, the digital, conversational assistant for Covid-19, is equipped to identify indicators of the virus and educate the public about the pandemic
• This interactive screening solution was released as a service to citizens seeking clear, authoritative information on the pandemic as well as a screener for symptoms and risks

SYDNEY, March 24, 2020 — IPsoft, the largest independent leader in enterprise AI, announced the launch of Digital Employee Amelia to help screen for indicators of the novel coronavirus (COVID-19), with the aim of helping authorities to “flatten the curve.” Whether sheltered-in-place or quarantined at home, any member of the general public can reach this AI-powered conversational assistant by voice call or browser to receive an assessment of risk and find additional information about the pandemic. While engaged in conversation, Amelia will assess a user based on current symptoms and potential risk factors based on the latest information from the Center for Disease Control and Prevention (CDC) and The World Health Organization (WHO).

As more American cities restrict movement, the new Amelia aims to provide the general public, as well as vulnerable populations, with accurate, on-demand information about COVID-19 with no risk of exposure. Older adults and people with underlying medical conditions constitute nearly 20 percent of the US population and are most at risk for developing serious complications from COVID-19.

This version of Amelia also aims to alleviate pressure on hospitals, clinics, physicians’ offices and medical care centers that are fielding non-urgent questions related to COVID-19. As a cognitive agent capable of interacting naturally with humans, Amelia can relieve health institutions so that they are able to focus their efforts on the populations with the greatest need.

“Levels of anxiety are growing across the country, and we think everyone can use a little peace of mind. We believe that Amelia can do that by bringing verifiable information regarding risk and response into people’s homes,” said Dr. S. Vincent Grasso (DO, MSIS, MBA), Global Practice Leader for Healthcare & Life Sciences at IPsoft. “By helping people to access information, we hope to reduce anxiety during this COVID-19 pandemic. Amelia provides a safe experience for consumers to access screening, without the need to travel to a facility and risk exposure.”

Best known as an enterprise solution, Amelia has been used by brands around the world to distill data and information to millions of customers and staff. To screen for COVID-19, Amelia will continuously be updated based on guidelines from the CDC and WHO.

Amelia is currently available to help screen for COVID-19 and can be reached at the following link on Firefox, Chrome, and mobile browsers: https://www.ipsoft.com/covid-19/

###

Additional information:

• Amelia does not provide medical advice or is intended to treat or diagnose. Amelia is only intended to assist with evaluating your own situation and for information purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Never ignore professional medical advice or delay in seeking treatment because of something you have read on this website or using IPsoft’s COVID-19 application.